0QZU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 481.73 USD -0.32%

Market Cap: $124.5B

V	Vertex Pharmaceuticals Inc LSE:0QZU	US
	Krsnaa Diagnostics Ltd BSE:543328	IN
	ABC Arbitrage SA LSE:0OPJ	FR
V	V2 Retail Ltd BSE:532867	IN
V	Volatus Aerospace Inc DUS:ABB	CA
C	Centuri Holdings Inc NYSE:CTRI	US
	Idacorp Inc F:IDJ	US
C	Creepy Jar SA F:3CJ	PL
V	Vesuvius PLC OTC:CKSNY	UK
M	Muenchener Rueckversicherungs Gesellschaft in Muenchen AG OTC:MURGF	DE
M	MOL Magyar Olajes Gazipari Nyrt OTC:MGYOY	HU
M	Marriott Vacations Worldwide Corp XETRA:M8V	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

41% > 26%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

47% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.